These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
66 related articles for article (PubMed ID: 20353537)
1. Serum testosterone is associated with aggressive prostate cancer in older men: results from the Baltimore Longitudinal Study of Aging. Morgentaler A; Rhoden EL; Guay A; Traish A BJU Int; 2010 Mar; 105(6):884-5; author reply 885-6. PubMed ID: 20353537 [No Abstract] [Full Text] [Related]
2. Development of a nomogram for predicting high-grade prostate cancer on biopsy: the significance of serum testosterone levels. Ide H; Yasuda M; Nishio K; Saito K; Isotani S; Kamiyama Y; Muto S; Horie S Anticancer Res; 2008; 28(4C):2487-92. PubMed ID: 18751439 [TBL] [Abstract][Full Text] [Related]
3. Serum testosterone and the risk of prostate cancer: potential implications for testosterone therapy. Parsons JK; Carter HB; Platz EA; Wright EJ; Landis P; Metter EJ Cancer Epidemiol Biomarkers Prev; 2005 Sep; 14(9):2257-60. PubMed ID: 16172240 [TBL] [Abstract][Full Text] [Related]
4. Hormonal predictors of prostate cancer. Sofikerim M; Eskicorapci S; Oruç O; Ozen H Urol Int; 2007; 79(1):13-8. PubMed ID: 17627161 [TBL] [Abstract][Full Text] [Related]
5. Serum measurements of testosterone, insulin-like growth factor 1, and insulin-like growth factor binding protein-3 in the diagnosis of prostate cancer among Korean men. Hong SK; Han BK; Jeong JS; Jeong SJ; Moon KH; Byun SS; Lee SE Asian J Androl; 2008 Mar; 10(2):207-13. PubMed ID: 18097534 [TBL] [Abstract][Full Text] [Related]
6. Serum inhibin--not a cause of low testosterone levels in hypogonadal prostate cancer? Lackner JE; Maerk I; Koller A; Bieglmayer C; Marberger M; Kratzik C; Schatzl G Urology; 2008 Nov; 72(5):1121-4. PubMed ID: 18407338 [TBL] [Abstract][Full Text] [Related]
7. Serum testosterone is associated with aggressive prostate cancer in older men: results from the Baltimore Longitudinal Study of Aging. Pierorazio PM; Ferrucci L; Kettermann A; Longo DL; Metter EJ; Carter HB BJU Int; 2010 Mar; 105(6):824-9. PubMed ID: 19751256 [TBL] [Abstract][Full Text] [Related]
8. High-grade prostate cancer is associated with low serum testosterone levels. Schatzl G; Madersbacher S; Thurridl T; Waldmüller J; Kramer G; Haitel A; Marberger M Prostate; 2001 Apr; 47(1):52-8. PubMed ID: 11304729 [TBL] [Abstract][Full Text] [Related]
9. Association between prostate cancer and serum testosterone levels. Zhang PL; Rosen S; Veeramachaneni R; Kao J; DeWolf WC; Bubley G Prostate; 2002 Nov; 53(3):179-82. PubMed ID: 12386917 [TBL] [Abstract][Full Text] [Related]
10. Is low serum free testosterone a marker for high grade prostate cancer? Hoffman MA; DeWolf WC; Morgentaler A J Urol; 2000 Mar; 163(3):824-7. PubMed ID: 10687985 [TBL] [Abstract][Full Text] [Related]
11. Nonsteroidal anti-inflammatory drugs and risk of prostate cancer in the Baltimore Longitudinal Study of Aging. Platz EA; Rohrmann S; Pearson JD; Corrada MM; Watson DJ; De Marzo AM; Landis PK; Metter EJ; Carter HB Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):390-6. PubMed ID: 15734963 [TBL] [Abstract][Full Text] [Related]
12. Low serum testosterone levels are associated with positive surgical margins in radical retropubic prostatectomy: hypogonadism represents bad prognosis in prostate cancer. Teloken C; Da Ros CT; Caraver F; Weber FA; Cavalheiro AP; Graziottin TM J Urol; 2005 Dec; 174(6):2178-80. PubMed ID: 16280759 [TBL] [Abstract][Full Text] [Related]
13. Are total prostate-specific antigen serum levels in cirrhotic men different from those in normal men? Vicentini FC; Botelho LA; Hisano M; Ebaid GX; Lucon M; Lucon AM; Srougi M Urology; 2009 May; 73(5):1032-5. PubMed ID: 19286245 [TBL] [Abstract][Full Text] [Related]
14. Associations between serum testosterone fall and cognitive function in prostate cancer patients. Salminen EK; Portin RI; Koskinen A; Helenius H; Nurmi M Clin Cancer Res; 2004 Nov; 10(22):7575-82. PubMed ID: 15569988 [TBL] [Abstract][Full Text] [Related]
15. Associations of serum testosterone with microvessel density, androgen receptor density and androgen receptor gene polymorphism in prostate cancer. Schatzl G; Madersbacher S; Haitel A; Gsur A; Preyer M; Haidinger G; Gassner C; Ochsner M; Marberger M J Urol; 2003 Apr; 169(4):1312-5. PubMed ID: 12629350 [TBL] [Abstract][Full Text] [Related]
16. Relationship between serum testosterone and measures of benign prostatic hyperplasia in aging men. Liu CC; Huang SP; Li WM; Wang CJ; Chou YH; Li CC; Huang CH; Wu WJ Urology; 2007 Oct; 70(4):677-80. PubMed ID: 17991536 [TBL] [Abstract][Full Text] [Related]
17. Serum testosterone and sex hormone-binding globulin concentrations and the risk of prostate carcinoma: a longitudinal study. Heikkilä R; Aho K; Heliövaara M; Hakama M; Marniemi J; Reunanen A; Knekt P Cancer; 1999 Jul; 86(2):312-5. PubMed ID: 10421267 [TBL] [Abstract][Full Text] [Related]
18. Circulating steroid hormones and the risk of prostate cancer. Severi G; Morris HA; MacInnis RJ; English DR; Tilley W; Hopper JL; Boyle P; Giles GG Cancer Epidemiol Biomarkers Prev; 2006 Jan; 15(1):86-91. PubMed ID: 16434592 [TBL] [Abstract][Full Text] [Related]
19. A broader role for 5ARIs in prostate disease? Existing evidence and emerging benefits. Montorsi F; Alcaraz A; Desgrandchamps F; Hammerer P; Schröder F; Castro R Prostate; 2009 Jun; 69(8):895-907. PubMed ID: 19267353 [TBL] [Abstract][Full Text] [Related]
20. Pretreatment serum testosterone level as a predictive factor of pathological stage in localized prostate cancer patients treated with radical prostatectomy. Imamoto T; Suzuki H; Fukasawa S; Shimbo M; Inahara M; Komiya A; Ueda T; Shiraishi T; Ichikawa T Eur Urol; 2005 Mar; 47(3):308-12. PubMed ID: 15716191 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]